Analysis of the association between salivary proteins and oral mucositis in patients with head and neck cancer undergoing IMRT: a longitudinal study.
Autor: | Agurto MG; Faculty of Dentistry, Universidad de los Andes, Santiago, Chile. mgonzaleza@uandes.cl., Carpenter GH; Faculty of Dental, Salivary Research, Centre for Host-Microbiome Interactions, Oral & Craniofacial Sciences, King's College London, London, UK., Bozorgi SS; Faculty of Dental, Salivary Research, Centre for Host-Microbiome Interactions, Oral & Craniofacial Sciences, King's College London, London, UK., Koller G; Department of Endodontics, Faculty of Dentistry, Centre for Host Microbiome Interactions, Oral & Craniofacial Sciences, King's College London, London, UK., Fenlon M; Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, Guy's Hospital, Floor 22, London, UK., Warburton F; Faculty of Dental, Oral Clinical Research Unit, Oral & Craniofacial Sciences, King's College London, London, UK., Bruce K; Institute of Pharmaceutical Science, King's College London, Franklin-Wilkins Building, King's College London, London, UK., Burke M; Guy's and St Thomas' NHS Foundation Trust, London, UK., Banerjee A; Centre of Oral Clinical Translational Sciences, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, Conservative & MI Dentistry, London, UK. |
---|---|
Jazyk: | angličtina |
Zdroj: | BMC oral health [BMC Oral Health] 2024 May 29; Vol. 24 (1), pp. 630. Date of Electronic Publication: 2024 May 29. |
DOI: | 10.1186/s12903-024-04400-9 |
Abstrakt: | Introduction: This longitudinal study assessed the association between salivary protein composition and the clinical onset/severity of oral mucositis (OM) in patients with head and neck tumours treated with intensity-modulated-radiotherapy (IMRT). Methods: Saliva samples/clinical data were obtained from 40 head and neck cancer patients treated at Guy's Hospital before -IMRT(T0) and after-IMRT (T1 = 6 m, T2 = 12 m) (ethics approval/consent). Salivary flow rate, total protein concentration, and secretion rate were determined from saliva samples and compared with pre-treatment values. OM was assessed, total/specific salivary proteins, including mucin 5B and 7, IgA, cystatin-S, albumin, and α-amylase, were quantified. Results: 95% patients experienced OM during IMRT, with 33 subjects reaching grade 2&3. At T1, there was a significant reduction in salivary flow rate, total protein secretion rate, α-amylase and cystatin-S compared to baseline. Remarkably IMRT did not significantly alter mucin 5B and 7, or the IgA secretion rate at any time point. At T1, all the analyzed proteins were associated with the OM outcomes. In addition, there was a significant inverse correlation between IgA concentration at T0 and the severity of OM during IMRT. Conclusion: This study revealed significant associations between several salivary proteins and OM in patients with head and neck cancer undergoing IMRT. Further longitudinal studies are needed to confirm these results. Clinical Significance: The study contributes to the understanding of certain salivary proteins association with OM. This could be the first step towards identifying potential salivary markers that could offer perspectives for personalized medicine approaches to improve their quality of life (QoL). Research Question: What is the association between salivary proteins and the occurrence and severity of OM in head and neck cancer patients? Aim: To assess the association between salivary protein composition with the clinical onset/severity of oral mucositis (OM) in head and neck cancer patients treated with intensity modulated radiotherapy. Null Hypothesis: There is no association between salivary proteins and onset/severity of OM in HNC patients. (© 2024. The Author(s).) |
Databáze: | MEDLINE |
Externí odkaz: |